未登录

C

Cristina Di Poto

georgetown university

H指数:16

被引数:1,097

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A microfluidic chip-based capillary zone electrophoresis-mass spectrometry method for measuring adenosine 5′-Triphosphate and its similar nucleotide analogues

ANALYTICA CHIMICA ACTA

IF6

2024-04-016

OAAI

Gut Microbiome Derived Trimethyl-n-oxide Exacerbates Inflammation And Induces Cardiac Fibrosis In Human Cardiac Fibroblasts And In Rodent Model Of Cardiorenal Disease

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2022-05-010

PRE

Metabolomic Profiling of Human Urine Samples Using LC-TIMS-QTOF Mass Spectrometry

JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY

IF2.7

2021-06-0912

PREAI

DNA Methylation Activates TP73 Expression in Hepatocellular Carcinoma and Gastrointestinal Cancer

SCIENTIFIC REPORTS

IF3.9

2019-12-1816

OAAI

Establishment of ornithine transcarbamylase deficiency-derived primary human hepatocyte with hepatic functions

EXPERIMENTAL CELL RESEARCH

IF3.5

2019-11-016

OAAI

Epigenetic regulation of TP73 expression in HCC and GI cancer

CANCER RESEARCH

IF16.6

2019-07-010

PRE

Metabolomic Analysis of Liver Tissues for Characterization of Hepatocellular Carcinoma

JOURNAL OF PROTEOME RESEARCH

IF3.6

2019-06-1256

OAAI

YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells

YAP/TAZ抑制诱导代谢和信号转导，导致NF2-Deficient肿瘤细胞的可靶向脆弱性

DEVELOPMENTAL CELL

IF8.7

2019-05-0184

OAAI

Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2017-04-3042

OAAI

INDEED: Integrated differential expression and differential network analysis of omic data for biomarker discovery

确实: 生物标志物发现的组学数据的整合差异表达和差异网络分析

IF4.3

2016-12-0125

OAAI

Topic model-based mass spectrometric data analysis in cancer biomarker discovery studies

IF3.7

2016-08-182

OAAI

LC-MS/MS-based serum proteomics for identification of candidate biomarkers for hepatocellular carcinoma

基于lc-ms/MS的血清蛋白质组学鉴定肝细胞癌候选生物标志物

IF3.9

2015-04-2970

OAAI

LC-MS Profiling of N-Glycans Derived from Human Serum Samples for Biomarker Discovery in Hepatocellular Carcinoma

JOURNAL OF PROTEOME RESEARCH

IF3.6

2014-08-0848

OAAI

Evaluation of Metabolite Biomarkers for Hepatocellular Carcinoma through Stratified Analysis by Gender, Race, and Alcoholic Cirrhosis

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2014-01-1210

OAAI

LC-MS Based Serum Metabolomics for Identification of Hepatocellular Carcinoma Biomarkers in Egyptian Cohort

JOURNAL OF PROTEOME RESEARCH

IF3.6

2012-11-01120

OA

Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis

ANALYTICA CHIMICA ACTA

IF6

2012-09-01143

OAAI

2-DE and LC-MS/MS for a Comparative Proteomic Analysis of BALf from Subjects with Different Subsets of Inflammatory Myopathies

JOURNAL OF PROTEOME RESEARCH

IF3.6

2009-04-1321

PRE

Proteomics of the Olfactory Stem Cells

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2009-02-010

OA

2-DE and MALDI-TOF-MS for a comparative analysis of proteins expressed in different cellular models of amyotrophic lateral sclerosis

ELECTROPHORESIS

IF2.5

2007-11-2611

PREAI

Optimizing separation efficiency of 2-DE procedures for visualization of different superoxide dismutase forms in a cellular model of amyotrophic lateral sclerosis

ELECTROPHORESIS

IF2.5

2007-11-262

PREAI